Jie Liu1, Mario Roederer. 1. ImmunoTechnology Section, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland 20895, USA.
Abstract
BACKGROUND: Cytotoxic T lymphocytes (CTL) are crucial for the host defense against viral infection. In many cases, this anti-viral immune response contributes to host pathogenesis, through inflammation and tissue destruction. Few studies have explored the relative susceptibility of infected cells to CTL killing, and the range of cell types that may be effectively killed by CTLs in vivo, both of which are key to understanding both immune control of infection and immune-related pathogenesis. METHODS: We developed and optimized a highly sensitive method to quantify the relative susceptibility of leukocyte subsets to CTL-mediated killing. Maximal sensitivity was achieved by uniquely measuring cell death occurring during the assay culture. RESULTS: We found that leukocyte subsets have a wide range of susceptibility to antigen-specific CTL-mediated lysis. Generally, T cells were more susceptible than B or NK cells, with CD4 T cells being more susceptible than CD8 T cells. In all lymphocyte lineages, susceptibility was greater for more differentiated subsets compared with their naïve counterparts; however, for dendritic cells, immature cells are more susceptible than mature cells. We focused on the susceptibility of T cell subsets, and found that naïve cells are far more resistant than memory cells, and in particular, CCR5+ or HLA-DR+ memory cells are highly susceptible to CTL-mediated killing. CONCLUSIONS: These results provide an explanation for the observation that certain subsets of CD4 T cells are ablated during chronic HIV infection, and indicate which subsets are most likely to contain the persistent viral reservoir.
BACKGROUND:Cytotoxic T lymphocytes (CTL) are crucial for the host defense against viral infection. In many cases, this anti-viral immune response contributes to host pathogenesis, through inflammation and tissue destruction. Few studies have explored the relative susceptibility of infected cells to CTL killing, and the range of cell types that may be effectively killed by CTLs in vivo, both of which are key to understanding both immune control of infection and immune-related pathogenesis. METHODS: We developed and optimized a highly sensitive method to quantify the relative susceptibility of leukocyte subsets to CTL-mediated killing. Maximal sensitivity was achieved by uniquely measuring cell death occurring during the assay culture. RESULTS: We found that leukocyte subsets have a wide range of susceptibility to antigen-specific CTL-mediated lysis. Generally, T cells were more susceptible than B or NK cells, with CD4 T cells being more susceptible than CD8 T cells. In all lymphocyte lineages, susceptibility was greater for more differentiated subsets compared with their naïve counterparts; however, for dendritic cells, immature cells are more susceptible than mature cells. We focused on the susceptibility of T cell subsets, and found that naïve cells are far more resistant than memory cells, and in particular, CCR5+ or HLA-DR+ memory cells are highly susceptible to CTL-mediated killing. CONCLUSIONS: These results provide an explanation for the observation that certain subsets of CD4 T cells are ablated during chronic HIV infection, and indicate which subsets are most likely to contain the persistent viral reservoir.
Authors: Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham Journal: J Virol Date: 2010-08-04 Impact factor: 5.103
Authors: Yanqin Ren; Szu Han Huang; Shabnum Patel; Winiffer D Conce Alberto; Dean Magat; Dughan Ahimovic; Amanda B Macedo; Ryan Durga; Dora Chan; Elizabeth Zale; Talia M Mota; Ronald Truong; Thomas Rohwetter; Chase D McCann; Colin M Kovacs; Erika Benko; Avery Wimpelberg; Christopher Cannon; W David Hardy; Alberto Bosque; Catherine M Bollard; R Brad Jones Journal: J Clin Invest Date: 2020-05-01 Impact factor: 14.808
Authors: Szu-Han Huang; Chase D McCann; Talia M Mota; Chao Wang; Steven M Lipkin; R Brad Jones Journal: Front Immunol Date: 2019-08-06 Impact factor: 7.561
Authors: Deanna A Kulpa; Aarthi Talla; Jessica H Brehm; Susan Pereira Ribeiro; Sally Yuan; Anne-Gaelle Bebin-Blackwell; Michael Miller; Richard Barnard; Steven G Deeks; Daria Hazuda; Nicolas Chomont; Rafick-Pierre Sékaly Journal: J Virol Date: 2019-11-26 Impact factor: 5.103
Authors: Marilia R Pinzone; Sam Weissman; Alexander O Pasternak; Ryan Zurakowski; Stephen Migueles; Una O'Doherty Journal: JCI Insight Date: 2021-08-23